AI-Enhanced Lung Preservation Tech for Transplantation

Publication ID: 24-11856944_0003_PTD
Published: October 26, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “AI-Enhanced Lung Preservation Tech for Transplantation,” Published Technical Disclosure No. 24-11856944_0003_PTD, Published October 26, 2025, available at https://archive.pr1or.art/24-11856944_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,856,944.

Background and Problem Solved

Current organ preservation techniques have limitations in terms of lung function prediction, provenance tracking, and personalized transplantation. The original patent's organ care solution for ex-vivo machine perfusion of donor lungs has been significantly enhanced by incorporating AI, IoT, and blockchain technologies to address these limitations.

Novelty and Inventive Step

The invention's synergistic integration of AI, IoT, and blockchain technologies with the original patent's organ care solution provides a novel and non-obvious approach to ex-vivo lung care. The use of AI for lung function prediction, IoT for real-time monitoring, and blockchain for provenance tracking represents a significant departure from existing organ preservation techniques.

Alternative Embodiments and Variations

Alternative embodiments of the invention could include the use of different AI algorithms, IoT sensor configurations, or blockchain platforms. Variations could also include the integration of additional technologies, such as machine vision or robotics, to further enhance the lung care system.

Potential Commercial Applications and Market

The intelligent ex-vivo lung care system has significant commercial potential in the organ transplantation market, particularly in the context of lung transplantation. The system's ability to enhance lung function prediction, provenance tracking, and personalized transplantation could increase the availability of donor lungs, reduce transplantation risks, and improve patient outcomes.

CPC Classifications

SectionClassGroup
A A01 A01N1/0226
A A01 A01N1/0247

Original Patent Information

Patent NumberUS 11,856,944
TitleOrgan care solution for ex-vivo machine perfusion of donor lungs
Assignee(s)TRANSMEDICS, INC.